Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group
- PMID: 10573045
- DOI: 10.1001/archinte.159.21.2553
Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group
Abstract
Background: Adverse drug events (ADEs) are common in hospitalized patients, but few empirical data are available regarding the strength of patient risk factors for ADEs.
Methods: We performed a nested case-control study within a cohort that included 4108 admissions to a stratified random sample of 11 medical and surgical units in 2 tertiary care hospitals during a 6-month period. Analyses were conducted on 2 levels: (1) using a limited set of variables available for all patients using computerized data available from 1 hospital and (2) using a larger set of variables for the case patients and matched controls from both hospitals. Case patients were patients with an ADE, and the matched control for each case patient was the patient on the same unit as the case patient with the most similar prevent length of stay. Main outcome measures were presence of an ADE, preventable ADE, or severe ADE.
Results: In the cohort analysis, electrolyte concentrates (odds ratio [OR], 1.7), diuretics (OR, 1.7), and medical admission (OR, 1.6) were independent correlates of ADEs. Independent correlates of preventable ADEs in the cohort analysis were low platelet count (OR, 4.5), antidepressants (OR, 3.3), antihypertensive agents (OR, 2.9), medical admission (OR, 2.2), and electrolyte concentrates (OR, 2.1). In the case-control analysis, exposure to psychoactive drugs (OR, 2.1) was an independent correlate of an ADE, and use of cardiovascular drugs (OR, 2.4) was independently correlated with severe ADEs. For preventable ADEs, no independent predictors were retained after multivariate analysis.
Conclusions: Adverse drug events occurred more frequently in sicker patients who stayed in the hospital longer. However, after controlling for level of care and preevent length of stay, few risk factors emerged. These results suggest that, rather than targeting ADE-prone individuals, prevention strategies should focus on improving medication systems.
Comment in
-
Adverse drug reactions in the elderly: need for dedicated databases.Arch Intern Med. 2000 Jun 12;160(11):1700-1. doi: 10.1001/archinte.160.11.1700. Arch Intern Med. 2000. PMID: 10847266 No abstract available.
Similar articles
-
The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group.JAMA. 1997 Jan 22-29;277(4):307-11. JAMA. 1997. PMID: 9002493
-
Risk factors for hospital admissions associated with adverse drug events.Pharmacotherapy. 2013 Aug;33(8):827-37. doi: 10.1002/phar.1287. Epub 2013 May 17. Pharmacotherapy. 2013. PMID: 23686895
-
Hospital admissions caused by adverse drug events: an Australian prospective study.Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027. Aust Health Rev. 2014. PMID: 24351707
-
Potential risks and prevention, Part 1: Fatal adverse drug events.Am J Health Syst Pharm. 2001 Jul 15;58(14):1317-24. doi: 10.1093/ajhp/58.14.1317. Am J Health Syst Pharm. 2001. PMID: 11471479 Review.
-
Characteristics of Adverse Drug Events Originating During the Hospital Stay, 2011.2013 Oct. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #164. 2013 Oct. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb–. Statistical Brief #164. PMID: 24354026 Free Books & Documents. Review.
Cited by
-
Clinical Effectiveness of Renal Transplant Outpatient Pharmaceutical Care Services in Korea.Healthcare (Basel). 2023 Sep 21;11(18):2597. doi: 10.3390/healthcare11182597. Healthcare (Basel). 2023. PMID: 37761794 Free PMC article.
-
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital.Rev Peru Med Exp Salud Publica. 2023 Jan-Mar;40(1):16-24. doi: 10.17843/rpmesp.2023.401.11563. Epub 2023 Jun 23. Rev Peru Med Exp Salud Publica. 2023. PMID: 37377231 Free PMC article.
-
Incidence and Economic Burden of Adverse Drug Reactions in Hospitalization: A Prospective Study in Korea.J Korean Med Sci. 2023 Feb 27;38(8):e56. doi: 10.3346/jkms.2023.38.e56. J Korean Med Sci. 2023. PMID: 36852852 Free PMC article.
-
Predictors of 1-year drug-related admissions in older multimorbid hospitalized adults.J Am Geriatr Soc. 2022 May;70(5):1510-1516. doi: 10.1111/jgs.17667. Epub 2022 Jan 22. J Am Geriatr Soc. 2022. PMID: 35064571 Free PMC article.
-
Drug-drug interactions in polypharmacy patients: The impact of renal impairment.Curr Res Pharmacol Drug Discov. 2021 Mar 29;2:100020. doi: 10.1016/j.crphar.2021.100020. eCollection 2021. Curr Res Pharmacol Drug Discov. 2021. PMID: 34909655 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
